LIPOSOMAL PROSTAGLANDIN FORMULATIONS
A method of treating a cell activation/adhesion syndrome in mammals, including humans, by the administration of a pros-taglandin associated with a liposome is disclosed. Such cell activation/adhesion syndromes may include reperfusion injury, sep-tic shock, myocardial infarction, adult respiratory di...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A method of treating a cell activation/adhesion syndrome in mammals, including humans, by the administration of a pros-taglandin associated with a liposome is disclosed. Such cell activation/adhesion syndromes may include reperfusion injury, sep-tic shock, myocardial infarction, adult respiratory distress syndrome, rheumatoid vasculitis, systemic vasculitis, lupus, post trau-matic shock, burn injury or restenosis after angioplasty. In a preferred embodiment, the prostaglandin is encapsulated in the liposomes. |
---|